Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in Natalizumab Population With Active Control
Clinical trial NCT01626248 · COMPLETED
Trial details
- NCT number
- NCT01626248
- Sponsor
- John F. Foley, MD
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2012-07-01
- Primary completion
- 2013-03-01
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.